Clinical trial
Effects of GSH and N-Acetylcysteine on Inflammatory Markers Among Adults With CVD Risk
NCT01550432 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of GSH and N-Acetylcysteine on Inflammatory Markers Among Adults With CVD Risk
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- July 31, 2012
- Enrollment
- 78 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperlipidemia, hypertension, insulin resistance, obesity